Cervical Cancer: It’s Not Only Preventable But Treatable
Overview Cervical cancer is developed when the cells of the cervix (entrance to the uterus from the vagina) grow...
Management of rare mutations in non-small cell lung cancer (NSCLC) – PART 3: HER2
Human epidermal growth factor receptor 2 (HER2) is a member of the ERBB receptor tyrosine kinase family. It is...
Management of rare mutations in non-small cell lung cancer (NSCLC) – PART 2: RET, NTRK1
RET RET (an abbreviation for Rearranged during Transfection) encodes a receptor tyrosine kinase for members of the glial cell...
Cancer may have started the fight but new research on oncology will open many doors and end the war
Cancer is a disease wherein a number of the body’s cells grow uncontrollably and spread to other body parts....
Infectious Disorders: In Light of Current Research
Infectious disease is defined as an illness that is transmitted from an infected source to a susceptible host, infected...
Genome sequencing project finds answers for 25% of rare disease patients in a study
Some patients with a suspected rare genetic disease go without a diagnosis for years or even throughout a lifetime....
Recent Medical Breakthroughs to See a Change in the World
Research in different areas of therapy for various diseases has led to a wide range of treatments. Various diseases...
How Oncology Research in 2021 Shed Light on Therapy Area?
New research on oncology is creating new knowledge in several areas of therapy. This year is characterized by the...
Management of rare mutations in non-small cell lung cancer (NSCLC) – PART 1: MET, ROS1, and ALK
Why do we make a fuss about rare mutations in NSCLC? In 2015, they only made up about 1-2%...
How to know the status of acute lymphoblastic leukemia from epigenetic DNA modification?
Hematological cancers were among the first to be discovered to have abnormal demethylation status. Excretion of epigenetic DNA modification...